bFGF could be a biomarker of malignancy in RS3PE syndrome: an ambispective single-center cohort analysis of 51 patients. Gan Y, Sun Y, Jin J, Wang Y, et al. Arthritis Res Ther 2021;23:261.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Gan Y, Sun Y, Jin J, Wang Y, et al. bFGF could be a biomarker of malignancy in RS3PE syndrome: an ambispective single-center cohort analysis of 51 patients. Arthritis Res Ther 2021;23:261.
PMID: 34654466